ENOV vs INMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

ENOV

38.0
AI Score
VS
INMD Wins

INMD

52.6
AI Score

Investment Advisor Scores

ENOV

38score
Recommendation
SELL

INMD

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ENOV INMD Winner
Revenue 2.25B 370.50M ENOV
Net Income -1.18B 93.83M INMD
Gross Margin 59.8% 78.5% INMD
Net Margin -52.7% 25.3% INMD
Operating Income -1.12B 85.39M INMD
ROE -79.5% 13.7% INMD
ROA -30.9% 12.2% INMD
Total Assets 3.83B 766.43M ENOV
Cash 36.39M 302.54M INMD
Current Ratio 2.02 9.88 INMD
Free Cash Flow 19.92M 84.28M INMD

Relative Price Performance (Last 90 Days)

ENOV 1M: +13.2% · 3M: -20.1% INMD 1M: -2.9% · 3M: -7.0%

Current Technical Phase

ENOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 61.5 · Price: $20.81

INMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 38

RSI (14): 37.5 · Price: $14.03

Fundamentals Snapshot

Metric ENOV INMD
Market Cap — —
Forward P/E 5.9 10.2
Trailing P/E — 11.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.0% 0.1%
EPS -19.23 1.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, INMD is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.